Skip to main content

US ClosedU.S. Closed

CLYM: Climb Bio, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Climb Bio, Inc. is a biopharmaceutical firm dedicated to crafting therapeutic solutions for inflammatory diseases driven by autoimmune responses.

52W Range

78thpctl

Volume

0.69×avg

Market Cap

834.32MUSD

P/E Ratio

-17.6TTM

Div Yield

-ann

Loading chart data...

Current StateState loading

Climb Bio, Inc.

CLYMNASDAQ Global Market·USD·Closed

Climb Bio, Inc.

CLYMNASDAQ·USD·Closed

$14.57

−3.25%

$14.57

−$0.49 (3.25%)

52W Range

78thpctl

Volume

0.69×avg

Mkt Cap

834.32MUSD

P/E

-17.6TTM

Div Yield

–ann